Human CD34+ hematopoietic stem cell-engrafted NSG™ or NSG™ variant mice (hu-CD34) develop multi-lineage human immune cells, and are a validated platform for immunology or immuno-oncology efficacy studies, and infectious disease research. Our inventory has CD34+ mice available for immediate shipment to your facility or efficacy study enrollment at ours.
We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.